Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients (2018)
- Authors:
- USP affiliated authors: FORLENZA, ORESTES VICENTE - FM ; GATTAZ, WAGNER FARID - FM
- Unidades: FM; FM
- DOI: 10.1007/s00406-017-0838-2
- Subjects: COLESTEROL; DOENÇA DE ALZHEIMER; METABOLISMO; DEMÊNCIA
- Language: Inglês
- Imprenta:
- Place of publication: Heidelberg
- Date published: 2018
- Source:
- Título do periódico: European archives of psychiatry and clinical neuroscience
- ISSN: 0940-1334
- Volume/Número/Paginação/Ano: v. 268, n. 5, p. 501-507, 2018
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
COSTA, Alana C.; JOAQUIM, Helena P. G.; NUNES, Valeria S.; et al. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, Heidelberg, v. 268, n. 5, p. 501-507, 2018. Disponível em: < http://dx.doi.org/10.1007/s00406-017-0838-2 > DOI: 10.1007/s00406-017-0838-2. -
APA
Costa, A. C., Joaquim, H. P. G., Nunes, V. S., Kerr, D. S., Ferreira, G. S., Forlenza, O. V., et al. (2018). Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients. European archives of psychiatry and clinical neuroscience, 268( 5), 501-507. doi:10.1007/s00406-017-0838-2 -
NLM
Costa AC, Joaquim HPG, Nunes VS, Kerr DS, Ferreira GS, Forlenza OV, Gattaz WF, Talib LL. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2018 ; 268( 5): 501-507.Available from: http://dx.doi.org/10.1007/s00406-017-0838-2 -
Vancouver
Costa AC, Joaquim HPG, Nunes VS, Kerr DS, Ferreira GS, Forlenza OV, Gattaz WF, Talib LL. Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients [Internet]. European archives of psychiatry and clinical neuroscience. 2018 ; 268( 5): 501-507.Available from: http://dx.doi.org/10.1007/s00406-017-0838-2 - Diagnosis and biomarkers of predementia in Alzheimer’s disease
- Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid
- Formal Thought Disorder and language impairment in schizophrenia
- Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease
- Decreased plasmatic spermidine and increased spermine in mild cognitive impairment and Alzheimer's disease patients
- Inhibition of phospholipase A2 increases Tau phosphorylation at Ser214 in embryonic rat hippocampal neurons
- Long-Term Lithium Treatment Increases cPLA2 and iPLA2 Activity in Cultured Cortical and Hippocampal Neurons
- Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients
- Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
- Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study
Informações sobre o DOI: 10.1007/s00406-017-0838-2 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
